Market Adoption Trends Coming Out of ASCO 2010

Today, Oncology Business Review (OBR) published a great article based on the results from the 3rd Annual MDoutlook Quick Poll following ASCO 2010. You can read the full article on OBR’s website (article). Many thanks to our friends at media partner OBR for developing and releasing this article so quickly after we published the analyzed results.

If you would like to receive a full copy of the MDoutlook Quick Poll analysis or learn more about the value and insight MDoutlook can deliver, please contact us using this form.

Arcas continues on growth path

We are pleased to report continued growth on a number of fronts!

Our team will welcome two valuable additions in July: Luan Dao, PhD will join the Medical Team as Global Medical Analyst and Jessica Mastrodomenico, MPH will strengthen our Operational Group as Manager, Client Projects. Luan most recently served as a post-doctoral fellow at Emory University with a focus on influenza and HPV. Jessica joins us from the CDC Foundation where she worked while completing her Master of Public Health with a concentration on prevention sciences.

We have also signed up three new clients for MDoutlook, our oncology intelligence platform. The clients specifically focus on prostate cancer, renal cell carcinoma and melanoma. Additionally, Arcas has welcomed new clients to its Outcome Optimizer offering in the area of oncology diagnostics and breast cancer. And our Business Optimizer offering has recently signed up tow consultancy projects focused on physician recruiting and oncology marketing.

Please contact us here for more information and if you are interested in joining a rapidly growing organization, either as client or associate.